Historical record - last NADAC publication: 4/20/2022
Product Information
DEFERASIROX 360 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $2.1034 per EA under NDC 69238148803. Its NADAC has been published 45 times since Apr 20, 2022.
The High Outlier badge above means this manufacturer's average price in the Deferasirox market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
360 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238148803
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/20/2022
Active Ingredients
DEFERASIROXApproval Type
Generic (ANDA)
FDA Application
ANDA210727On Market Since
1/2/2020
Pharmacological Classes
Price Statistics
The NADAC for DEFERASIROX 360 MG TABLET has been published 45 times since Apr 20, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1034 per EA |
|---|---|
| All-time high | $2.1034 (Feb 22, 2023) |
| All-time low | $2.1034 (Apr 20, 2022) |
| Median price | $2.1034 |
| Average price | $2.1034 |
| Largest weekly change | 0.0% (Apr 27, 2022) |
| Weeks tracked | 45 |
| Tracking since | Apr 20, 2022 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEFERASIROX 360 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEFERASIROX 360 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $2.1034 per EA (NDC 69238148803), effective Feb 22, 2023.
How has the price of DEFERASIROX 360 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEFERASIROX 360 MG TABLET has held within roughly two percent of its current level. It has been tracked across 45 weekly CMS publications since Apr 20, 2022.
What are the highest and lowest recorded NADAC prices for DEFERASIROX 360 MG TABLET?
Since Apr 20, 2022, the NADAC for DEFERASIROX 360 MG TABLET has ranged from a low of $2.1034 (Apr 20, 2022) to a high of $2.1034 (Feb 22, 2023), with a median of $2.1034 per EA.
Are there cheaper alternatives to DEFERASIROX 360 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DEFERASIROX 360 MG TABLET, is $1.4953 per EA — about 29% below DEFERASIROX 360 MG TABLET.
Who manufactures DEFERASIROX 360 MG TABLET?
DEFERASIROX 360 MG TABLET (NDC 69238148803) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification